Notably, the anti-inflammatory effects were especially pronounced in individuals with MetS, likely because this population often exhibits elevated baseline concentrations of systemic inflammation, including higher circulating C-reactive protein (CRP), IL-6, and TNF [28]. Here, CRP is linked to metabolic syndrome.